Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234)
Clinical trial NCT00770315 · COMPLETED
Trial details
- NCT number
- NCT00770315
- Sponsor
- ALK-Abelló A/S
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-05-01
- Enrollment
- 784
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.